Characterization of the extra-intestinal pathogenic Escherichia coli ST131 clone among isolates recovered from urinary and bloodstream infections in the United Kingdom
The multidrug-resistant ST131-O25b clone of Escherichia coli is well established as a significant cause of extra-intestinal infections worldwide. However, there have been only two small regional studies comparing ST131 isolates from the UK. Therefore, we characterized 143 ST131 E. coli (38 urinary, 105 bloodstream) collected between January 2011 and March 2012 from 38 centres located across the UK and Republic of Ireland. Phenotypic and genotypic characterization of clonal isolates revealed high rates of resistance to amoxicillin-clavulanate (56 %), cefotaxime (32 %), ciprofloxacin (79 %), temocillin (69 %, bloodstream isolates only), gentamicin (67 %) and trimethoprim–sulfamethoxazole (59 %). The most frequently detected extended-spectrum beta-lactamase was CTX-M-15 (87 %), predominantly encoded on IncF plasmids, although it was also associated with IncU plasmids in two isolates. The majority of UK ST131 clonal isolates possessed the O25b antigen (97 %) and the H30 fimH allele (92 %), but three serogroups (O19a, O136 and O153) novel to ST131 were identified among our strains. Contrary to previous reports, UK ST131-O16 isolates were typically susceptible to ciprofloxacin and lacked beta-lactamase genes (n = 12/12). In summary, ST131 strains of E. coli circulating in the UK possess characteristic clonal features, but are becoming more diverse than other international ST131 populations.
AnaniasM., YanoT.2008; Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res 41:877–883 [View Article][PubMed]
BSAC2011 BSAC Methods for Antimicrobial Susceptibility Testing, Version 10.2 Birmingham, UK: British Society for Antimicrobial Chemotherapy; http://www.bsac.org.uk
CalhauV., RibeiroG., MendonçaN., Da SilvaG. J.2013; Prevalent combination of virulence and plasmidic-encoded resistance in ST 131 Escherichia coli strains. Virulence 4:726–729 [View Article][PubMed]
DahbiG., MoraA., LópezC., AlonsoM. P., MamaniR., MarzoaJ., CoiraA., García-GarroteF., PitaJ. M., other authors. 2013; Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases. Int J Antimicrob Agents 42:347–351 [View Article][PubMed]
DallenneC., Da CostaA., DecréD., FavierC., ArletG.2010; Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65:490–495 [View Article][PubMed]
GibreelT. M., DodgsonA. R., CheesbroughJ., FoxA. J., BoltonF. J., UptonM.2012; Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from northwest England. J Antimicrob Chemother 67:346–356 [View Article][PubMed]
GrossR., RoweB.1985; Serotyping of Escherichia coli. In The Virulence of Escherichia coli pp. 345–360 Edited by SussmanM. Cambridge, UK: Cambridge University Press;
LauS. H., KaufmannM. E., LivermoreD. M., WoodfordN., WillshawG. A., CheastyT., StamperK., ReddyS., CheesbroughJ., other authors. 2008; UK epidemic Escherichia coli strains A-E, with CTX-M-15 β-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 62:1241–1244 [View Article][PubMed]
LivermoreD. M., HopeR., BrickG., LillieM., ReynoldsR., BSAC Working Parties on Resistance Surveillance. 2008; Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001–06. J Antimicrob Chemother 62:(Suppl 2)ii41–ii54[PubMed]
PettyN. K., Ben ZakourN. L., Stanton-CookM., SkippingtonE., TotsikaM., FordeB. M., PhanM. D., Gomes MorielD., PetersK. M., other authors. 2014; Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A 111:5694–5699 [View Article][PubMed]
PriceL. B., JohnsonJ. R., AzizM., ClabotsC., JohnstonB., TchesnokovaV., NordstromL., BilligM., ChattopadhyayS., other authors. 2013; The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio 4:e00377–e00313 [View Article][PubMed]
TurtonJ. F., KaufmannM. E., WarnerM., CoelhoJ., DijkshoornL., van der ReijdenT., PittT. L.2004; A prevalent, multiresistant clone of Acinetobacter baumannii in southeast England. J Hosp Infect 58:170–179 [View Article][PubMed]
Characterization of the extra-intestinal pathogenic Escherichia coli ST131 clone among isolates recovered from urinary and bloodstream infections in the United Kingdom